Dexcom Inc (NASDAQ: DXCM) kicked off on Friday, down -5.21% from the previous trading day, before settling in for the closing price of $58.02. Over the past 52 weeks, DXCM has traded in a range of $56.44-$93.25.
During the last 5-year period, the sales growth of Healthcare Sector giant was 39.06%. While this was happening, its average annual earnings per share was recorded 25.67%. With a float of $384.61 million, this company’s outstanding shares have now reached $390.00 million.
Dexcom Inc (DXCM) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Dexcom Inc is 1.39%, while institutional ownership is 96.15%. The most recent insider transaction that took place on Sep 05 ’25, was worth 53,934. In this transaction Director of this company sold 667 shares at a rate of $80.86, taking the stock ownership to the 22,667 shares. Before that another transaction happened on Sep 04 ’25, when Company’s EVP, Chief HR Officer sold 1,466 for $80.00, making the entire transaction worth $117,280. This insider now owns 105,223 shares in total.
Dexcom Inc (DXCM) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 0.45 earnings per share (EPS), lower than consensus estimate (set at 0.5) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.86% during the next five years compared to 39.06% growth over the previous five years of trading.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
Take a look at Dexcom Inc’s (DXCM) current performance indicators. Last quarter, stock had a quick ratio of 1.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.75. Likewise, its price to free cash flow for the trailing twelve months is 20.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.80, a number that is poised to hit 0.65 in the next quarter and is forecasted to reach 2.48 in one year’s time.
Technical Analysis of Dexcom Inc (DXCM)
Looking closely at Dexcom Inc (NASDAQ: DXCM), its last 5-days average volume was 11.68 million, which is a jump from its year-to-date volume of 4.51 million. As of the previous 9 days, the stock’s Stochastic %D was 11.41%.
During the past 100 days, Dexcom Inc’s (DXCM) raw stochastic average was set at 2.48%, which indicates a significant decrease from 4.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.51 in the past 14 days, which was higher than the 2.42 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $69.24, while its 200-day Moving Average is $77.58. However, in the short run, Dexcom Inc’s stock first resistance to watch stands at $57.46. Second resistance stands at $59.93. The third major resistance level sits at $61.60. If the price goes on to break the first support level at $53.32, it is likely to go to the next support level at $51.65. Should the price break the second support level, the third support level stands at $49.18.
Dexcom Inc (NASDAQ: DXCM) Key Stats
The company with the Market Capitalisation of 21.45 billion has total of 390,016K Shares Outstanding. Its annual sales at the moment are 4,033 M in contrast with the sum of 576,200 K annual income. Company’s last quarter sales were recorded 1,209 M and last quarter income was 283,800 K.
